Home Archives 2013 March

Monthly Archives: March 2013

Drug Patent Expirations for March 2013

TradenameApplicantGeneric NamePatent NumberPatent Expiration
THALOMIDCelgenethalidomide8,143,283Mar 1, 2013
THALOMIDCelgenethalidomide7,723,361Mar 1, 2013
THALOMIDCelgenethalidomide6,235,756Mar 1, 2013
ZOMETANovartiszoledronic acid4,939,130*PEDMar 2, 2013
LUNESTASunovion Pharms Inceszopiclone6,864,257*PEDMar 2, 2013
RECLASTNovartiszoledronic acid4,939,130*PEDMar 2, 2013
NATROBAParapro Llcspinosad5,496,931Mar 5, 2013
FLO-PREDTaroprednisolone acetate6,102,254Mar 11, 2013
ABRAXANEAbraxis Biosciencepaclitaxel5,498,421Mar 12, 2013
COMBIVENT RESPIMATBoehringer Ingelheimalbuterol sulfate; ipratropium bromide5,497,944Mar 12, 2013
RYBIX ODTShionogi Inctramadol hydrochloride5,464,632Mar 22, 2013
XOPENEXSunovionlevalbuterol hydrochloride5,362,755Mar 25, 2013
XOPENEX HFASunovionlevalbuterol tartrate5,362,755Mar 25, 2013
SILENORSomaxondoxepin hydrochloride5,502,047Mar 26, 2013
LOVAZASmithkline Beechamomega-3-acid ethyl esters5,502,077Mar 26, 2013
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.
Contact Us with any questions.

If your reader cannot render the information below, go to http://www.DrugPatentWatch.com/innovation to see the latest expirations

This newsletter is a free service of DrugPatentWatch
DrugPatentWatch offers comprehensive details on FDA approved drugs, developers, and their patents

Drug Patent Expirations for February 20 2013

TradenameApplicantGeneric Name Patent Expiration
ARRANONSmithkline BeechamnelarabineFeb 20, 2013

*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.


DrugPatentWatch Infographics

Top
selling drugs

What are the Top-selling Drugs?

More infographics »

DrugPatentWatch Serves Your Competitive Intelligence Needs

Subscribers have access to valuable datasets, including:
  • Patent litigation
  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Drug Master Files
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison. Contact Us with any questions.

The above list does not discriminate between dominant and non-dominant patents. Drugs listed above may be protected by additional patents and other regulatory protections. See the DrugPatentWatch database for complete details

DISCLAIMER:
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
All trademarks and applicant names are the property of their respective owners or licensors.